Trials / Completed
CompletedNCT01908062
Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn how best to treat substance use disorders in an HIV clinic setting. Specifically, the purpose of this pilot study is to learn if extended-release naltrexone (XR-NTX) would be a feasible and acceptable treatment for HIV-infected individuals with opioid or alcohol use disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Extended Release Naltrexone | |
| OTHER | Treatment As usual |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2013-07-25
- Last updated
- 2019-03-19
- Results posted
- 2019-02-26
Locations
2 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01908062. Inclusion in this directory is not an endorsement.